Aditx Therapeutics (ADTX)
(Delayed Data from NSDQ)
$2.37 USD
+0.10 (4.41%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $2.30 -0.07 (-2.95%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum D VGM
Price, Consensus and EPS Surprise
ADTX 2.37 +0.10(4.41%)
Will ADTX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ADTX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ADTX
Indivior PLC (INDV) Tops Q3 Earnings and Revenue Estimates
Marinus Pharmaceuticals (MRNS) Reports Q2 Loss, Tops Revenue Estimates
ADTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Harpoon Therapeutics, Inc. (HARP) Beats Q2 Earnings and Revenue Estimates
Xencor (XNCR) Reports Q2 Loss, Tops Revenue Estimates
Is the Options Market Predicting a Spike in Aditx (ADTX) Stock?
Other News for ADTX
Aditxt, Inc. Announces Strategic Acquisition of Appili Therapeutics
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
Canopy Growth, Exact Sciences, Stereotaxis among healthcare movers
Aditxt signs agreement to acquire Appili Therapeutics